SLC5A1 and Obesity: We determined whether transgenic mice with cardiomyocyte-specific knockdown of SGLT1 (TGSGLT1-DOWN) had attenuation of cardiomyopathy after induction of obesity and insulin resistance by exposure to a high fat diet (HFD) from ages 8–28 weeks.